Background
==========

Cluster headache (CH) is an excruciating primary headache disorder, classified with similar conditions known as trigeminal autonomic cephalalgias \[[@B1]\]. Patients always describe the pain of a single attack as being worse than anything else they have experienced. Headaches are characterized by unilateral pain usually involving the orbital or periorbital region innervated by the first (ophthalmic) division of the trigeminal nerve and are accompanied by ipsilateral autonomic features, including lacrimation, conjunctival injection, nasal congestion and/or rhinorrhea, ptosis and/or miosis, and periorbital edema. CH show male predominance and a periodic occurrence and circadian rhythm of cluster attacks \[[@B2]-[@B4]\]. Diagnostic criteria for CH have been established by the International Headache Society \[[@B1]\]. Knowledge and understanding of CH derive primarily from studies in Western populations \[[@B5]-[@B13]\]. The clinical characteristics of CH in other regions of the world, including Asia, however, are not well understood \[[@B14],[@B15]\]. To our knowledge, little is known about the characteristics of CH in patients from the Chinese mainland. We have characterized the clinical profile of CH in China by surveying CH patients registered at a headache clinic in Beijing, China.

Methods
=======

The study population consisted of patients diagnosed with CH, as defined by the second edition of the International Classification of Headache Disorders (ICHD-II) \[[@B1]\], on first consultation from May 2010 to August 2012 at the International Headache Center of Chinese PLA General Hospital in Beijing, China, accredited by International Headache Society. For each patient, a detailed clinic questionnaire for headache disorders was completed by a certified neurologist in headache center during the initial consultation and the diagnosis was made by at least two headache specialists together. Magnetic resonance imaging of the head/brain was applied to rule out symptomatic origin for every headache patient.

A detailed database for each headache patient was set up including clinical information such as age, gender, course of disease, pain intensity, possible trigger factors, autonomic features, additional features (e.g. nausea, vomiting, photophobia, phonophobia, behaviors during attacks, and aggravation after activity), frequency and duration of clusters, frequency and duration of attack onset, family history of headache, history of smoking and drinking, and quality of life. Maximum pain intensity was estimated using a visual analogue scale (VAS). The study protocol was approved by the ethics committee of the Chinese PLA General Hospital, Beijing.

All measurements were reported as mean ± SD. Categorical variables were compared using the chi-square test, and continuous variables were compared using Student's *t*-test or one-way analysis of variance (ANOVA). SPSS for Windows, Version 20.0, was used for statistical analyses with the significance level set at *P =* 0.05.

Results
=======

Area distribution of patients
-----------------------------

Patients came from 16 regions of China (Figure [1](#F1){ref-type="fig"}). Most of them lived in North and Eastern China including Hebei (29, 24.2%), Beijing (25, 20.8%), Shanxi (15, 12.5%), Inner Mongolia (8, 6.7%), Henan (8, 6.7%), Shandong (10, 8.3%). Other areas consist of Anhui (4, 3.3%), Gansu (3, 2.5%), Heilongjiang (2, 1.7%), Jilin (3, 2.5%), Jiangsu (3, 2.5%), Fujian (2, 1.7%), Liaoning (3, 2.5%), Shaanxi (2, 1.7%), Tianjin (2, 1.7%) and Zhejiang (1, 0.8%).

![**Regional distribution of cluster headache patients in the current study (n = 120).** Patients came from 16 regions of China. Colors from dark to light indicate different proportion of headache patients from higher to lower (5 levels: 20--30%, 10--20%, 5--10%, 1--5%, and \<1%).](1129-2377-14-27-1){#F1}

Study population
----------------

Of the 120 patients enrolled in this study, 105 were male and 15 were female, giving a male-to-female (M: F) ratio of 7:1; of these, 111 (92.5%) had episodic CH (ECH) and 9 (7.5%) had chronic CH (CCH). Mean age at first consultation at our clinic was 34.9 ± 10.5 years (males, 34.7 ± 10.6 years vs. females, 36.5 ± 9.7 years). Mean age at onset was 26.7 ± 10.9 years and was similar in males and females (26.6 ± 10.8 years vs. 28.0 ± 11.4 years, P = 0.652). The mean VAS of all patients was 8.9 ± 1.4, 8.9 ± 1.4 in males and 8.6 ± 1.6 in females (P = 0.454) (Table [1](#T1){ref-type="table"}). One CH male patient has already suffered trigeminal neuralgia. Two patients (1.6%, 2 M) also had migraine headaches and five patients (4.2%, 3 M, 2 F) had tension-type headaches. Eight patients (6.7%) gave a family history of CH (diagnosed with identified and classic clinical features), including mother (two patients), father (four patients) and other relatives (two patients). Peak age at onset was 20--29 years for both males and females (Figure [2](#F2){ref-type="fig"}).

![**Age distribution at onset for cluster headache.** The peak age at onset for male and female were both in the 2^nd^ decade of life.](1129-2377-14-27-2){#F2}

###### 

Demographics of subjects with cluster headache

  **Patient characteristics**          **Total N = 120**   **Males n = 105**   **Females n = 15**   **P-value**
  ------------------------------------ ------------------- ------------------- -------------------- -------------
  Type of cluster headache                                                                           
   Episodic                            111                 97                  14                   1.00
   Chronic                             9                   8                   1                     
  Age in years (mean ± SD)             34.9 ± 10.5         34.7 ±10.6          36.5 ± 9.7            
  Age at onset in years (mean ± SD)    26.7 ± 10.9         26.6 ± 10.8         28.0 ± 11.4          0.652
  Pain intensity (VAS)                 8.9 ± 1.4           8.9 ± 1.4           8.6 ± 1.6            0.454
  Family history of Cluster headache   8                                                             
   Mother                              2                                                             
   Father                              4                                                             
   Others                              2                                                             

\*The ratio of males to female was 7:1.

History of smoking and drinking
-------------------------------

Sixty-six (55%) CH patients had a positive history of tobacco exposure including 59 (49.2%) current smokers and 7 (5.8%) ex-smokers. Other 45% (54/120) sufferers stated they had never smoked prior to cluster headache onset. Almost 49.2% (59/120) of the surveyed patients stated they drank alcohol and 5% (6/120) have stopped drinking.

Sites and laterality of headache
--------------------------------

The most commonly reported location of CH was temporal region (75.0%), followed by retro-orbital region (68.3%), forehead (32.5%), vertex (32.5%) and occipital (22.5%) (Table [2](#T2){ref-type="table"}). Other sites of pain included neck (4.2%), teeth (4.2%), ear (4.2%), cheek (2.5%) and nose (1.7%). Strictly unilateral headache was most frequently reported (right side 51.7%, left side 36.7%), followed by predominantly right side (4.2%) and left side (3.3%). However, six (5.0%) patients also experienced equal attacks on shifting sides among different attacks.

###### 

The locations and laterality of pain in CH patients

                           **Total (N = 120)**   **Males (n = 105)**   **Females (n = 15)**   **P-value**
  ------------------------ --------------------- --------------------- ---------------------- -------------
  **Sites of pain**                                                                            
  Temporal                 90 (75.0)             78 (74.3)             12 (80.0)              0.759
  Retro-orbital            82 (68.3)             71 (67.6)             11 (73.3)              0.773
  Forehead                 39 (32.5)             36 (34.3)             3 (20.0)               0.381
  Vertex                   39 (32.5)             32 (30.5)             7 (46.7)               0.244
  Occipital                27 (22.5)             24 (22.9)             3 (20.0)               1.00
  Neck                     5 (4.2)               5 (4.8)               0                      1.00
  Teeth                    5 (4.2)               5 (4.8)               0                      1.00
  Ear                      5 (4.2)               5 (4.8)               0                      1.00
  Cheek                    3 (2.5)               3 (2.9)               0                      1.00
  Nose                     2 (1.7)               2 (1.9)               0                      1.00
  **Laterality of pain**                                                                       
  Right-side only          62 (51.7)             55 (52.4)             7 (46.7)               0.785
  Left-side only           43 (35.8)             40 (38.1)             3 (20.0)               0.251
  Predominant right-side   5 (4.2)               4 (3.8)               1 (6.7)                0.493
  Predominant left-side    4 (3.3)               2 (1.9)               2 (13.3)               0.076
  Changing sides           6 (5.0)               4 (3.8)               2 (13.3)               0.163

Results are reported as number of patients (percent).

Cranial autonomic and additional features in patients with CH
-------------------------------------------------------------

Lacrimation (72.5%) was the most consistently reported autonomic feature, followed by conjunctival injection (63.3%), rhinorrhea (33.3%), nasal congestion (32.5%), and less commonly, blepharoedema (23.3%), facial sweating (18.3%), Ptosis/miosis (16.7%) (Table [3](#T3){ref-type="table"}). Although cranial autonomic symptoms (CAS) of CH commonly occurred unilaterally, bilateral CAS including lacrimation (2/87), rhinorrhea (2/40), and facial sweating (3/22) were also observed in our cohort. During acute attacks, 60.0% of individuals experienced nausea, 41.7% reported photophobia, and 40.8% experienced phonophobia. In addition, 38.3% of patients experienced restless behavior, and 45.8% reported that physical activity exacerbated their pain. None of patients experienced visual or other kinds of aura symptoms before cluster attacks. There was no statistically significant difference in any of the clinical characteristics between male and female patient (Tables [2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}).

###### 

Cranial autonomic and additional features in patients with cluster headache

                                        **Total (N = 120)**   **Males (N = 105)**   **Females (N = 15)**   **P-value**
  ------------------------------------- --------------------- --------------------- ---------------------- -------------
  **Autonomic features**                                                                                    
  Lacrimation                           87(72.5)※             77(73.3)              10(66.7)               0.553
  Conjunctival injection                76(63.3)              67(63.8)              9(60.0)                0.781
  Rhinorrhea                            40(33.3)※             38(36.2)              2(13.3)                0.140
  Nasal congestion                      39(32.5)              37(35.2)              2(13.3)                0.139
  Ptosis/miosis                         20(16.7)              17(16.2)              3(20.0)                0.714
  Facial sweating                       22(18.3)\#            20(19.0)              2(13.3)                0.736
  Blepharoedema                         28(23.3)              23(21.9)              5(33.3)                0.338
  **Additional features**                                                                                   
  Nausea                                72(60.0)              64(61.0)              8(53.3)                0.585
  Vomiting                              40(33.3)              36(34.3)              4(26.7)                0.771
  Photophobia                           50(41.7)              43(41.0)              7(46.7)                0.782
  Phonophobia                           49(40.8)              42(40.0)              7(46.7)                0.780
  Sense of restlessness and agitation   46(38.3)              40(33.3)              6(40.0)                1.00
  Aggravation by physical activities    55(45.8)              46(43.8)              9(60.0)                0.277
  **Aura**                              0                     0                     0                       

Results are reported as number of patients (percent). ※ The symptom occurred bilaterally in two patients. \# The symptom occurred bilaterally in three patients.

Periodicity of CH
-----------------

We found that 38.3% of patients had \<1 cluster period and 35.8% for 1--2 cluster periods per year respectively. Only nine (7.5%) had \> 2 cluster periods per year and 11.7% of patients have the first experience of cluster (Table [4](#T4){ref-type="table"}). Almost 70.8% of individuals (85 patients) commented on a seasonal propensity of bout onset. This occurred mostly in spring (41/120, 34.2%). However, these periods were less frequent during the summer months (19/120, 15.8%) than during other two seasons including autumn (30/120, 25.0%) and winter (26/120, 21.7%) (Figure [3](#F3){ref-type="fig"}). The duration of cluster attacks were 1--2 months in 32.5% of patients, 2 weeks to less than 1 month in 28.3%, less than 2 weeks in 14.2% and more than 2 months in 6.7% (Table [4](#T4){ref-type="table"}).

![**Season of onset attacks in cluster headache.** A seasonal propensity of bout onset occurred mostly in spring and less frequent during the summer months.](1129-2377-14-27-3){#F3}

###### 

Frequency and duration of clusters and onset of attacks

                                      **Total (N = 120)**   **Males (n = 105)**   **Females (n = 15)**
  ----------------------------------- --------------------- --------------------- ----------------------
  **Frequency of clusters**                                                        
  More than 2 times/yr                9 (7.5)               7 (6.7)               2 (13.3)
  1-2 times/yr                        43 (35.8)             36 (34.3)             7 (46.7)
  Less than 1 time/yr                 46 (38.3)             42 (40.0)             4 (26.7)
  First experience of cluster         14 (11.7)             13 (12.4)             1 (6.7)
  Irregular                           8 (6.7)               7 (6.7)               1 (6.7)
  **Duration of clusters**                                                         
  Less than 2 weeks                   17 (14.2)             14 (13.3)             3 (20.0)
  From 2 weeks to less than 1 month   34 (28.3)             27 (25.7)             7 (46.7)
  From 1 to 2 months                  39 (32.5)             36 (34.3)             3 (20.0)
  More than 2 months                  8 (6.7)               8 (7.6)               0
  First experience of cluster         14 (11.7)             13 (12.4)             1 (6.7)
  Irregular                           8 (6.7)               7 (6.7)               1 (6.7)
  **Frequency of onset of attacks**                                                
  More than 2 times/day               16 (13.3)             12 (11.4)             4 (26.7)
  1 to 2 times/day                    88 (73.3)             81 (77.1)             7 (46.7)
  Less than 1 time/day                16 (13.3)             12 (11.4)             4 (26.7)
  **Duration of onset of attacks**                                                 
  Less than 1 h                       21 (17.5)             18 (17.1)             3 (20.0)
  From 1 h to less than 2 h           47 (39.2)             42 (40.0)             5 (33.3)
  From 2 h to 3 h                     41 (34.2)             36 (34.3)             5 (33.3)
  More than 3 h                       11 (9.2)              9 (8.6)               2 (13.3)

Results are reported as number of patients (percent).

Attacks occurred 1--2 times per day in 73.3% of patients, \>2 times and \<1 time per day both in 13.3% (Table [4](#T4){ref-type="table"}). Eighty-one (67.5%) patients reported that their headaches occurred at a fixed time, more commonly from 7 am to 10 am (40%, 48/120) and from 2 pm to 4 pm (20%, 24/120) (Figure [4](#F4){ref-type="fig"}). There are also 39 patients (32.5%) who complained irregular headache attacks per day. We found that cluster attacks ranged in duration from 1 h to less than 2 h in 39.2% and from 2 h to 3 h in 34.2% of patients. Other 17.5% comment on the attack duration less than 1 h and 9.2% more than 3 h (Table [4](#T4){ref-type="table"}). The duration of attacks were 1.5 (1--2.25) hours for males and 1.5 (1-3) for females respectively (P = 0.923) (Figure [5](#F5){ref-type="fig"}).

![**Time of onset attacks in cluster headache.** Headaches occurred more commonly from 7 am to 10 am and from 2 pm to 4 pm.](1129-2377-14-27-4){#F4}

![**Duration of attacks in cluster headache.** The duration of attacks were 1.5 (1--2.25) hours for males and 1.5 (1-3) for females respectively (P = 0.923).](1129-2377-14-27-5){#F5}

Possible trigger factors
------------------------

Thirty-three of 59 (55.9%) patients who had consumed alcohol reported headaches after alcohol consumption. Thirty-one (25.8%) patients felt that weather or temperature changes triggered their headache. Twenty-six (21.7%) patients experienced a headache attack when they had insufficient sleep and sixteen (13.3%) patients aggravated after fatigue. Fourteen (11.7%) patients complained of headaches after stress or labile mood. Finally, 4 patients reported that some special substances could induce headache attack (2 for cayenne pepper, 1 for gourmet power and 1 for stimulatory odour).

Quality of life for CH patients
-------------------------------

CH had a negative impact on Quality of life (QoL) (Table [5](#T5){ref-type="table"}). Average scores about the eight items of WHOQoL-8 in people with CH including life quality, health level, daily life ability, satisfied with yourself, interpersonal relationship, habitation condition, daily life energy and payment ability were 2.38 ± 0.81, 2.08 ± 0.84, 2.68 ± 0.65, 2.57 ± 0.64, 2.85 ± 0.58, 2.73 ± 0.58, 2.09 ± 0.77 and 2.10 ± 0.60, respectively. It seems that the scores were lower than the data of migraine from a nationwide population-based headache survey in the mainland of China (Table [5](#T5){ref-type="table"}) \[[@B16]\].

###### 

World Health Organization quality of life-8 mean scores (SD) for cluster headache

                                **Cluster headache (N = 120)**   **Migraine (N = 464)**\[[@B16]\]
  ---------------------------- -------------------------------- ----------------------------------
  Life quality                           2.38 (0.81)                       3.22 (0.67)
  Health level                           2.08 (0.84)                       2.98 (0.83)
  Daily life ability                     2.68 (0.65)                       3.35 (0.78)
  Satisfied with yourself                2.57 (0.64)                       3.45 (0.80)
  Interpersonal relationship             2.85 (0.58)                       3.76 (0.68)
  Habitation condition                   2.73 (0.58)                       3.34 (0.84)
  Daily life energy                      2.09 (0.77)                       3.03 (0.72)
  Payment ability                        2.10 (0.60)                       2.60 (0.66)

04 of each item represents 5 grades of living quality from good to bad.

Time delay for correct diagnosis
--------------------------------

Only 13 patients (10.8%) had previously been diagnosed with CH. Mean time to diagnosis from first symptoms was 8.2 ± 7.1 years (range, 0--35 years). In 40% (48/120) of the CH patients, it took 10 years (14.2%) or longer (25.8%) to receive a correct diagnosis (Table [6](#T6){ref-type="table"}). Only the minority of patients (10.8%) had a proper diagnosis of cluster headache in less than 1 year from symptom onset.

###### 

Time delay for correct diagnosis of cluster headache

  **Time delay to diagnosis**    **N (%)**
  ----------------------------- -----------
  Less than 1 year               13 (10.8)
  1 year                          2 (1.7)
  2 years                        10 (8.3)
  3 years                        10 (8.3)
  4 years                        10 (8.3)
  5 years                        10 (8.3)
  6 years                         6 (5.0)
  7 years                         4 (3.3)
  8 years                         5 (4.2)
  9 years                         2 (1.7)
  10 years                       17 (14.2)
  More than 10 years             31 (25.8)

Results are reported as number of patients (percent).

Discussion
==========

To our knowledge, this study is the first survey of a clinic-based sample of patients with CH in mainland China. Most clinical characteristics of CH reported in this study are consistent with other studies from Western and Eastern regions in the world, which included gender dominance for male \[[@B4]-[@B15],[@B17]-[@B22]\], similar age at onset \[[@B5]-[@B7],[@B9],[@B13]-[@B15],[@B18],[@B19]\], temporal or retro-orbital regions as common sites of pain \[[@B5],[@B7],[@B13]-[@B15]\], lacrimation as the most frequent autonomic feature \[[@B5],[@B7],[@B13]-[@B15]\], high frequencies of migrainous features, low frequency of positive family history and seasonal propensity in spring and autumn (Table [7](#T7){ref-type="table"}). Yet, it is also worth noting some discrepancies between the current and previous results.

###### 

Clinical characteristics of CH from different regions in the world

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                           **UK**\[[@B5]\]**2002**           **Germany**\[[@B6]\]**2006**      **Germany**\[[@B7]\]**2012**                **Italy**\[[@B9]\]**2005**   **USA**\[[@B13]\]**2012**         **Japan**\[[@B15]\]**2011**          **Taiwan**\[[@B14]\]**2004**         **Mainland China**
  ---------------------------------------- --------------------------------- --------------------------------- ------------------------------------------- ---------------------------- --------------------------------- ------------------------------------ ------------------------------------ ---------------------------------------
  **M:F Ratio**                            2.5:1                             3.5:1                             3.4 :1                                      1.3:1                        2.6:1                             3.8: 1                               6.4: 1                               7:1

  **CCH (%)**                              21%                               16.7%                             31.1%                                       19%                          \--                               3.5%                                 0                                    7.5%

  **Mean age at onset (yrs)**              28.4 (ECH) 37 (CCH)               \--                               31.6                                        35.7                         21-30^※^                          31.0                                 26.9                                 26.7

  **Family history of CH**                 5%                                \--                               \--                                         \--                          18%                               \--                                  5.8%                                 6.7%

  **Common sites of pain**                 Retro-orbital, temporal, upper\   \--                               Peri-orbital, occipital, orofacial          \--                          Retro-orbital, upper teeth, jaw   Retro-orbital, temporal, occipital   Temporal, retro-orbital, occipital   Temporal, retro-orbital, forehead
                                           teeth                                                                                                                                                                                                                                                    

  **Predominant laterality**               Right                             \--                               \--                                         \--                          Right                             Right                                Right                                Right

  **Most cranial autonomic features**      Lacrimation (91%)                 \--                               Conjunctival injection and/or lacrimation   \--                          Lacrimation (91%)                 Lacrimation (66.3%)                  Lacrimation (83%)                    Lacrimation (72.5%)

  **Most additional features**             Photophobia (56%)                 Photophobia/Phonophobia (61.2%)   Photophobia/Phonophobia (73.2%)             \--                          Photophobia (48%)                 Nausea (39.5%)                       Phonophobia (58%)                    Nausea (60.0)%

  **Sense of agitation or restlessness**   93%                               67.9%                             83%                                         \--                          99.2%                             69.8%                                51%                                  38.3%

  **Aura**                                 14%                               23%                               \--                                         \--                          21%                               \--                                  1%                                   0

  **Most common duration of attacks**      72-159 min                        45-180 min (67.9%)                98 ± 75                                     \--                          \--                               From 1 h to less than 2 h (46.5%)    From 1 h to less than 2 h (34%)      From 1 h to less than 2 h (39.2%)

  **Most common attack time**              Nocturnally (73%)                 \--                               Nocturnally                                 \--                          Between 12 am and 3 am            Nocturnally(47.7%)                   Midnight (28%), afternoon (27%)      Between 7 am and 10 am, 2 pm and 4 pm

  **Seasonal propensity**                  Spring and Autumn                 \--                               Spring                                      \--                          Oct., Sep., Apr., Mar. and Nov.   \--                                  Dec., Mar.                           Spring
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

CH: cluster headache; CCH: chronic cluster headache; ECH: episodic cluster headache; ※: Peak age onset (36%).

In current study the CH was much more prevalent in men than in women, with an M: F ratio of 7:1. This data was similar to findings in Taiwan (6.4: 1) \[[@B14]\], but a little higher than other reported M: F ratios ranging from 1.3:1 to 3.8:1 \[[@B5]-[@B7],[@B9],[@B13],[@B15]\]. Manzoni \[[@B20],[@B21]\] have observed a time-related decrease in CH male predominance over the years and speculated that lifestyle may play an important role in the development of CH. Therefore, it may be conceivable that people from mainland China and Taiwan have similar M: F ratio due to their approximation of the lifestyle and cultural factors.

Of our 120 patients, only 9 (7.5%) had CCH. Other studies in Asian subjects have also reported a low prevalence of CCH (0--3.5%) \[[@B14],[@B15]\]. This ratio is relatively much higher, however, in Western populations, in which 16.7--31.1% of patients with CH have been diagnosed with CCH \[[@B5]-[@B7],[@B9]\]. The lower prevalence of CCH in Asian patients may be due to racial, lifestyle or cultural factors.

Temporal or retro-orbital regions were predominant sites of pain in CH patients, under the distribution of the first division of the trigeminal nerve (Table [7](#T7){ref-type="table"}). Other areas such as upper teeth, jaw and maxilla were also very common in Western populations \[[@B5],[@B7],[@B13],[@B23]\]. However, the pain of CH patients in current study was mainly focused on areas distributed by the first division of the trigeminal nerve and rarely on sites dominated by the second and third division of the trigeminal nerve (Table [2](#T2){ref-type="table"}). This clinical feature was also very common in other Eastern patients, including Japanese and Taiwanese patients (Table [7](#T7){ref-type="table"}).

Aura phenomena, similar to those experienced during migraine including visual and sensory phenomena, have been found to precede attacks in 5.9% to 21% of Western CH patients (Table [7](#T7){ref-type="table"}) \[[@B5],[@B6],[@B13],[@B23]-[@B25]\], which is the same prevalence of aura in migraine sufferers. This symptom appears to occur in both male and female patients with CH and in both chronic and episodic CH. None of our patients, however, were found to experience auras before cluster attacks. Similarly, only 1% of patients from Taiwan experienced aura \[[@B14]\]. The difference between Western and Eastern CH suffers may be also due to racial and genetic factors.

Studies in Western patients showed that 67.9% to 99.2% experience a sense of restlessness and agitation during an attack \[[@B5]-[@B7],[@B13]\]. In contrast, we found that only 38.3% of our CH patients experienced restless and agitation. This finding is in agreement with results in other Asian populations, in that 51% of patients from Taiwan \[[@B14]\] and 69.8% of patients from Japan \[[@B15]\]. This discrepancy between Eastern and Western CH patients may be due to ethnic, social and/or cultural factors. We also found that 45.8% of headaches were aggravated by physical activities, a percentage higher than in Caucasian (21.7%) \[[@B6]\] and Taiwanese (7%) \[[@B14]\] patients, but similar to that of patients in Japan (31.0%) \[[@B15]\].

The signature feature of CH is its rhythmicity, which uniquely displays both a circannual and circadian periodicity \[[@B2]-[@B4]\]. We have observed a seasonal propensity of CH, with more attacks occurring in the spring and fewer during the summer than at other times of the year, a result consistent with previous findings \[[@B5],[@B7],[@B13],[@B14]\]. The periodicity of CH suggests the involvement of the suprachiasmatic nucleus (SCN) of the hypothalamus, the biological clock \[[@B26]-[@B31]\]. Marked seasonal variations have been observed in the volume, total cell number and number of vasopressin expressing cells of the human SCN, with the SCN being smaller during the summer than during any other season of the year \[[@B32]\]. This may explain, at least in part, the lower prevalence of attack during the summer months in current study. We also found CH commonly occurred from 7 am to 10 am and from 2 pm to 4 pm compared to other time. However, we didn't demonstrate most of the headache attacks occurred nocturnally as previous reports \[[@B5],[@B7],[@B13],[@B15]\]. This discrepancy in circadian rhythmicity of CH attacks might be due to insignificant diurnal variations in the volume or vasopressin cell number of the human SCN in contrast with the annual cycle of the SCN \[[@B32]\].

Recent results from the United States Cluster Headache survey have revealed the differences between female and male CH including age of onset, family history, comorbid conditions, aura symptoms, pain locations and associated symptoms \[[@B33]\]. The data supported a previous study from a tertiary headache centre, which found some different characteristics in women with CH \[[@B22]\]. However, the current study showed no statistically significant difference in any of the clinical characteristics between male and female patient. The small sample size of our female patient population may result in such limit.

In the study we applied World Health Organization Quality of Life-8 (WHOQoL-8) to evaluate the quality of life in CH patients. This rating scale has also been widely used in a nationwide population-based headache survey in the mainland of China \[[@B16]\]. It seems that the scores of 8 items in CH patients were significantly lower than the data in migraineurs from above-mentioned survey. This may indicated CH had a more negative impact on quality of life than migraine.

Only 10.8% of our patients had previously been diagnosed with CH, a lower percentage than in other Asian countries, including Japan (14%). It took 10 years or even longer to receive a correct diagnosis for most of the CH patients in the study. These findings suggest that CH often remains unrecognized or misdiagnosed in China and that physicians may be unaware of this condition. Educating physicians about this recognizable and treatable condition and its diagnosis should be addressed.

This study had several limitations. Firstly, the clinical features were collected retrospectively and that this may result in a recall bias as compared to a prospective data collection with diaries. However, CH is a severe and excruciating headache disorder and thus the majority of the patients were easily to recall the clinical information about attacks. These may reduce the bias during interview. Moreover, the study has a relatively small number of CH patients, especially for female suffers. Lastly, patients were enrolled from a single headache clinic, although they came from 16 different regions in China.

Conclusion
==========

In summary, this study is the first to describe the clinical characteristics of CH in Chinese patients based on a clinic sample. Most of the clinical characteristic of these patients were consistent with results in other Asian and in Western patients, including similar age at onset, male predominance, temporal or retro-orbital regions as common sites of pain, similar pain intensity of primary headaches, lacrimation as the most frequent autonomic symptom, high frequencies of migrainous features, low frequency of positive family history and seasonal propensity in spring and autumn. We found that several characteristics were similar to those of other Asian populations, but differed from results in Western patients, including the low percentage of patients with chronic CH, pain sites mainly focused on areas distributed by the first division of the trigeminal nerve, the relative low frequency of restlessness and absent aura before headache attack. These may be due to different lifestyle, genetic, racial and cultural factors between Eastern and Western CH patients.
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